study,trt,class,mean,sd,se,n
abou-raya 2012,placebo,placebo,9.7,2.2,,144
abou-raya 2012,duloxetine ,snri,5.2,1.7,,144
aragona 2005,citalopram ,ssri,42.9,12.8,,15
aragona 2005,reboxetine ,nari,38.9,10.7,,14
ash 1999,placebo,placebo,7.94,6.97,,23
ash 1999,dothiepin ,tca,7.05,8.29,,25
boyle 2012,pregabalin ,nonad,52.4,,10,19
boyle 2012,amitriptyline ,tca,51.7,,8,23
boyle 2012,duloxetine ,snri,51,,8.8,23
cardenas 2002,placebo,placebo,11.2,8.6,,40
cardenas 2002,amitriptyline ,tca,12.4,10.9,,44
carette 1994,placebo,placebo,2.57,1.84,,36
carette 1994,amitriptyline ,tca,2.41,1.86,,78
carette 1994,cyclobenzaprine ,nonad,2.2,1.59,,70
dickens 2000,placebo,placebo,23.3,9,,48
dickens 2000,paroxetine ,ssri,23.2,8.3,,44
gilron 2009,gabapentin ,nonad,61.6,,2.6,46
gilron 2009,nortriptyline ,tca,61.7,,2.5,50
gilron 2009,gabapentin + nortriptyline ,tca,64.3,,2.5,50
gilron 2015,morphine ,nonad,2.1,,0.4,51
gilron 2015,nortriptyline ,tca,1.5,,0.4,51
gilron 2015,nortriptyline + morphine ,tca,1.8,,0.4,51
gilron 2016,placebo,placebo,70.3,,2.8,39
gilron 2016,pregabalin ,nonad,76.1,,2.8,39
gilron 2016,duloxetine ,snri,75.8,,2.8,39
gilron 2016,pregabalin + duloxetine ,snri,78.9,,2.9,39
ginsberg 1998,placebo,placebo,156,51,,28
ginsberg 1998,pirlindole ,maoi_rev,153,51,,33
goldenberg 1996,placebo,placebo,9.3,6.5,,19
goldenberg 1996,amitriptyline ,tca,8.7,6,,20
goldenberg 1996,fluoxetine ,ssri,7.8,4.7,,22
goldenberg 1996,amitriptyline + fluoxetine ,tca + ssri,7.4,4.4,,18
goldman 2010,placebo,placebo,10.2,7.7,,59
goldman 2010,amitriptyline ,tca,8.4,6.9,,59
goodkin 1990,placebo,placebo,20.77,16.7,,19
goodkin 1990,trazodone ,sari,28.97,25.05,,21
graff-radford 2000,amitriptyline ,tca,11.1,7.5,,11
graff-radford 2000,amitriptyline + fluphenazine ,tca,7.2,6.03,,12
graff-radford 2000,fluphenazine ,nonad,14.2,6.5,,13
graff-radford 2000,placebo,placebo,14,14.3,,13
hadianfard 2012,acupuncture ,nonad,2.2,2.6,,15
hadianfard 2012,fluoxetine ,ssri,3.6,3.1,,15
hannonen 1998,moclobemide ,maoi_rev,15.4,21.1,,43
hannonen 1998,amitriptyline ,tca,2.9,7.7,,42
hannonen 1998,placebo,placebo,13.2,20.2,,45
hudson 2021,nortriptyline ,tca,51.4,10.9,,102
hudson 2021,placebo,placebo,51.7,10,,103
hussain 2011,melatonin ,nonad,2.17,,0.72,27
hussain 2011,fluoxetine ,ssri,3.64,,0.87,24
hussain 2011,fluoxetine + melatonin ,ssri,3.17,,0.63,27
hussain 2011,fluoxetine + melatonin ,ssri,3,,0.65,23
kayiran 2010,neurofeedback ,nonad,4.78,,0.827,18
kayiran 2010,escitalopram ,ssri,8.22,,0.765,18
keefe 2010,placebo,placebo,4.48,3.74,,28
keefe 2010,sertraline ,ssri,7.05,8.45,,30
keefe 2010,coping skills training ,nonad,7.05,8.45,,29
keefe 2010,coping skills training + sertraline ,ssri,4.48,3.74,,28
khoromi 2007,placebo,placebo,9,8.5,,28
khoromi 2007,morphine ,nonad,9.6,8.5,,28
khoromi 2007,nortriptyline ,tca,7.3,7.1,,28
khoromi 2007,morphine + nortriptyline ,tca,6,5,,28
lee 2010,placebo,placebo,50.3,14.2,,21
lee 2010,venlafaxine ,snri,55.1,19.6,,22
macfarlane 1986,placebo,placebo,60.5,10,,13
macfarlane 1986,trimipramine ,tca,57.3,8.7,,14
machado 2018,waitlist ,nonad,14.62,9.43,,21
machado 2018,amitriptyline ,tca,11.86,9.24,,21
machado 2018,amitriptyline + splint ,tca,12.17,13.1,,23
machado 2018,acupuncture ,nonad,16.38,11.3,,13
matthey 2013,placebo,placebo,36,10.4,,39
matthey 2013,milnacipran ,snri,45,11.9,,38
muller 2008,placebo,placebo,8.2,1.1,,26
muller 2008,escitalopram ,ssri,4.3,1.1,,25
nct 2003,cognitive behavioural therapy ,nonad,48.4,8.1,,33
nct 2003,nortriptyline + cognitive behavioural therapy ,tca,50.8,10.4,,38
nct 2003,disease management ,nonad,53.3,10.6,,19
nct 2003,nortriptyline + disease management ,tca,52.6,10,,26
nct 2011,placebo,placebo,9,7,,12
nct 2011,milnacipran ,snri,6,4,,26
otto 2008,placebo,placebo,10.8,10.7,,41
otto 2008,escitalopram ,ssri,10.3,10.7,,41
pakfetrat 2019,saffron/crocin ,nonad,19,3.97,,26
pakfetrat 2019,citalopram ,ssri,19.4,4.65,,21
razazian 2014,carbamazepine ,nonad,2.4,0.6,,78
razazian 2014,pregabalin ,nonad,1.41,0.5,,77
razazian 2014,venlafaxine ,snri,1.63,0.8,,69
richards 2015,placebo,placebo,9.5,7.3,,59
richards 2015,venlafaxine ,snri,9.5,6.5,,64
robinson 2004,placebo,placebo,16.1,13.1,,18
robinson 2004,amitriptyline ,tca,12.9,8.5,,19
schukro 2016,placebo,placebo,46.5,12.5,,21
schukro 2016,duloxetine ,snri,50,11.6,,21
sencan 2004,aerobic exercise ,nonad,9.15,2.92,,20
sencan 2004,paroxetine ,ssri,9.9,2.11,,20
sencan 2004,tens ,nonad,15.4,3.6,,20
shakiba 2018,saffron/crocin ,nonad,8.96,3.48,,23
shakiba 2018,duloxetine ,snri,8.71,3.95,,23
sofat 2016,placebo,placebo,5.1,2.87,,22
sofat 2016,pregabalin ,nonad,4.1,3.59,,22
sofat 2016,duloxetine ,snri,3.8,4.44,,21
spinhoven 2010,placebo,placebo,7,3.3,,23
spinhoven 2010,paroxetine ,ssri,4.7,3,,23
spinhoven 2010,cognitive behavioural therapy ,nonad,4.9,3.9,,23
staud 2015,placebo,placebo,2.3,2.6,,18
staud 2015,milnacipran ,snri,2.6,2.7,,17
suttiruksa 2016,placebo,placebo,72,11.5,,13
suttiruksa 2016,mirtazapine ,nassa,81,14.4,,13
suttiruksa 2016,mirtazapine ,nassa,83,12.4,,14
tetreault 2018,placebo,placebo,7.15,7.04,,20
tetreault 2018,duloxetine ,snri,8.32,9.12,,19
urquhart 2018,placebo,placebo,8.71,1,,57
urquhart 2018,amitriptyline ,tca,7.78,0.8,,61
vranken 2011,placebo,placebo,73,19,,23
vranken 2011,duloxetine ,snri,73,19,,21
wolfe 1994,placebo,placebo,3,2.58,,9
wolfe 1994,fluoxetine ,ssri,1.5,1.78,,15